Which Hedge Funds Own LCTX — Lineage Cell Therapeutics Inc

7 of the hedge funds we track hold LCTX, worth $8.2M combined as of the Q2 2026 13F filings.

Versus the prior quarter: 1 added, 6 trimmed, 4 exited.

7 of those are hedged quant multi-strategy books, not directional conviction.

• Millennium Management — $4.0M (TRIM)
• Renaissance Technologies — $1.8M (TRIM)
• Marshall Wace — $1.7M (TRIM)

Insider buying at LCTX · All tracked funds